Association of Endothelin-I and A symmetric Dimethylarginine Levels with Insulin Resistance in Type-2 Diabetes Mellitus Patients

Abstract

Endothelin-I (ET-I) is one of the potent vasoconstrictors secreted from endothelial cells when needed. Many studies revealed the elevation of serum ET-I with human diabetes and microangiopathies. Since insulin resistance is a case of mixed diabetic and pre-diabetic cases, many risk factors beyond obesity and inflammation are proposed. The current study aims to demonstrate the association between serum ET-I and asymmetric dimethylarginine (ADMA) and insulin resistance in type 2 diabetes mellitus (T2DM). Sera of 73 subjects were enrolled currently (control= 35 subjects, and 38 with T2DM for more than 7 years), aged (40-60) years old, with distinct body mass index (BMI) ≤ 25 for control volunteers and (BMI) ≥ 25 for obesity and diabetes patients. Peripheral serum ET-I and ADMA levels were significantly (P≤ 0.0001) higher in T2DM than the control subjects. Receiver operating characteristic curve analysis regarded ET-I and ADMA as good markers for T2DM disease and insulin resistance, correlations between ET-I and anthropometrics revealed a strong increase of urotensin-II (UII), ADMA, homeostatic model assessment for insulin resistance (HOMA-IR) and hemoglobin A1C (HbA1C) with an increase of ET-I. These results are supported by the data of multiple regression analysis, showing that HOMA-IR, HbA1C, UII, BMI, and mean arterial pressure (MAP) are related to ET-I independently. The endothelin-I and ADMA had a positive relationship with increase insulin resistance and may serve as prognostic and diagnostic clinical biomarkers of insulin resistance. Collectively, Therefore, these measurements could evaluate the incidence of DM, and help to better rise up the knowledge about the progression of DM complications.

التنبؤ المبكر بالاعتلال الكلوي لمرضى عراقين مصابين بالسكري النوع الثاني بدلالة تقييم بعض العوامل البيوكيمائية ذات الصلة

“…Connective tissue growth factor (CTGF) expression is modest in healthy adult kidneys but is significantly elevated in a number of renal disorders, where it plays an important role in the development of glomerular and tubular interstitial fibrosis involved in cell migration, proliferation and differentiation, connective tissue growth factor (CTGF) acts either directly to promote fibrosis 39 .Our current study demonstrated an increase in connective tissue growth factor, which indicates glomerular and tubular damage and fibrosis in diabetic patients. This finding is consistent with Koszegi, S., et al who found elevated serum connective tissue growth factor (CTGF) expression as a strong predictor of renal fibrosis 40 .…”

Determining ACE-2 Level and Some Relevant Biochemical Parameters and studying the effect of Gender in Iraqi Diabetic Patients with Glomeruli and Renal Tubules Fibrosis as Early Prediction Marker

“…TGF-causes mesangial enlargement due to mesangial cell hypertrophy, proliferation (and eventually apoptosis), and the production of extracellular matrix (ECM). It also causes endothelium to mesenchymal transition, which results in glomerular myofibroblasts, a significant source of ECM, to occur 50,51 . Current study showed a significant difference between male and female in ACE-2 levels.…”

Potential Benefits of Ethanol extract of Anredera cordifolia for Antiobesity of High Fat diet-Induced Obesity in White Male Rat Wistar

“…Obesity is defined as an accumulation of mature adipocytes in adipose tissue. It is characterized by the increase in adipose tissue mass [1][2][3][4][5] due to the increase in adipocyte number…”